Jurnal Internasional Membalikkan agen anti-faktor Xa dan kebutuhan yang tidak terpenuhi pada pasien trauma

Download Disini
Jurnal Internasional Membalikkan agen anti-faktor Xa dan kebutuhan yang tidak terpenuhi pada pasien trauma

Download Journal Here

Andexanet alpha, a reversing agent for anticoagulants that inhibits factor Xa, was recently licensed in the United States. We discuss the impact of this license in current practice and review in detail the problem of neglected and developing clinical areas: reversing the effect of the factor Xa inhibitor anticoagulation in traumatized trauma patients. We identify areas of practice that require research so that treatment of bleeding trauma patients who receive direct factor Xa inhibitors can be improved.

Download the Journal Here

Download Disini

Leave a reply "Jurnal Internasional Membalikkan agen anti-faktor Xa dan kebutuhan yang tidak terpenuhi pada pasien trauma"

Author: 
    author